HEPION PHARMACEUTICALS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2018-12-31 was $36.44K.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2018-09-30 was $0.00.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2018-06-30 was $73.08K.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2018-03-31 was $186.52K.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, issued for services for fiscal 2018 was $296.04K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2018-12-31 | $36.44K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | $296.04K 10-K · filed 2020-05-14 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | |
| 2018-06-30 | $73.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | |
| 2018-03-31 | $186.52K 10-Q · filed 2019-05-15 | |
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |